| Half-life | 20 hours |
| Clearance Route | hepatic |
| Active Metabolites | yes |
| Notes | Used as appetite stimulant in wasting syndrome. Dose varies widely; 400–800 mg/day typical. Does not treat tumour. |
Severity: Severe
Adverse Effects:
Thromboembolism, adrenal suppression, edema, hyperglycemia
Contraindications:
Estrogen/progestin dependent cancers caution; active DVT/PE
Precautions:
Long-term use may cause adrenal axis suppression; tapering needed after prolonged therapy